Medicare AdvantageCoverageMedium impact
MA11.116a, Laparoscopic, Percutaneous, and Transcervical Techniques for Uterine Fibroid Myolysis
Independence Blue Cross·OB-GYN, Radiology·Medical Policy
Effective date
Mar 5, 2025
We identified it
Jun 19, 2026
Summary
Medicare Advantage policy MA11.116a covering laparoscopic, percutaneous, and transcervical techniques for uterine fibroid myolysis has been reissued effective March 5, 2025. This policy update affects coverage criteria for minimally invasive fibroid treatment procedures under Medicare Advantage plans.
Action Required
By March 5, 2025: Review updated Medicare Advantage policy MA11.116a for uterine fibroid myolysis procedures. OB-GYN and interventional radiology staff should verify current coverage criteria and documentation requirements for laparoscopic, percutaneous, and transcervical fibroid treatments. Update prior authorization workflows if requirements have changed.